U S Physical Therapy INC /NV Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Nchacha Etta, EVP & Chief Financial Officer of U S Physical Therapy Inc /Nv, received 6,831 shares of common stock on September 14, 2026.
NYSE
Peter Francis Minan, a Director of U S Physical Therapy Inc /Nv, purchased 6 shares of common stock on June 12, 2026.
NYSE
Eric Joseph Williams, President and COO of U S Physical Therapy Inc /Nv, reported a transaction in 714 shares of common stock on August 20, 2026.
NYSE
Jason Travis Curtis, Interim CFO of U S Physical Therapy Inc /Nv, reported a transaction in 40 shares of common stock on August 20, 2026.
NYSE
Richard Binstein, EVP Gen'l Counsel & Secretary of U S Physical Therapy Inc /Nv, reported a transaction in 450 shares of common stock on August 20, 2026.
NYSE
Graham D. Reeve, COO of U S Physical Therapy Inc /Nv, reported a transaction in 762 shares of common stock on August 20, 2026.
NYSE
Director Peter Minan acquired 780 shares of U.S. Physical Therapy, Inc. common stock through open market purchases.
NYSE
Director Regg E. Swanson filed an amendment to correct the reported transaction price of a restricted stock grant.
NYSE
Director Anne Motsenbocker filed an amendment to correct the reported transaction price of a restricted stock grant from $61.61 to $0.00.
NYSE
Director Peter Francis Minan filed an amendment to correct the reported transaction price of a restricted stock grant from $61.61 to $0.00.
NYSE
Director Kathleen A. Gilmartin filed an amendment to correct the reported transaction price of a restricted stock grant.
NYSE
Anne Motsenbocker, a Director at U.S. Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.
NYSE
Regg E. Swanson, a Director at US Physical Therapy Inc., has acquired 2,306 shares of common stock.
NYSE
Peter Francis Minan, a Director at US Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.
NYSE
Bernard A. Harris Jr., a director at U.S. Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.
NYSE
Director Kathleen Gilmartin acquired 2,306 shares of U.S. Physical Therapy Inc. common stock on May 19, 2026, as part of a restricted stock grant.
NYSE
U.S. Physical Therapy's COO, Graham D. Reeve, reported the sale of 662 common shares at a weighted average price of $78.86, while retaining a significant holding.
NYSE
U.S. Physical Therapy's Chairman and CEO, Christopher J. Reading, was granted 25,000 shares of restricted common stock, aligning his interests with long-term shareholder value.
NYSE
U.S. Physical Therapy's President and COO, Eric Joseph Williams, was granted 15,000 restricted shares of common stock, vesting through March 2030.
NYSE
U.S. Physical Therapy COO Graham D. Reeve was granted 10,000 shares of restricted common stock, increasing his direct beneficial ownership.
NYSE
U.S. Physical Therapy's EVP, General Counsel & Secretary, Richard Binstein, was granted 10,000 restricted common shares.
NYSE
U.S. Physical Therapy's CFO, Carey P. Hendrickson, received a grant of 10,000 restricted common shares, increasing total beneficial ownership to 37,808 shares.
NYSE
U.S. Physical Therapy COO Graham D. Reeve sold 743 shares of common stock at a weighted average price of $71.01 per share.
NYSE
Form 4: USPH Director Buys 4,000 Shares
Kathleen A. Gilmartin, a director at U.S. Physical Therapy Inc., purchased 4,000 shares of common stock at $69 per share.
NYSE
U.S. Physical Therapy Director Nancy Ham sold 600 shares of common stock at $81.71 per share, as disclosed in a recent SEC Form 4 filing.
NYSE
U.S. Physical Therapy's President and COO, Eric Joseph Williams, sold 1,000 shares of common stock for $85.25 per share under a pre-arranged trading plan.
NYSE
U.S. Physical Therapy's Chairman and CEO, Christopher J. Reading, sold 2,000 shares of common stock for $83.53 per share, while still holding over 114,000 shares.
NYSE
U.S. Physical Therapy's Chief Financial Officer, Carey P. Hendrickson, reported the sale of 698 shares of common stock for $86.11 per share.
NYSE
U.S. Physical Therapy COO Graham D. Reeve sold 763 shares of common stock for approximately $84.97 per share under a pre-arranged plan.
NYSE
U.S. Physical Therapy Inc. EVP Richard Binstein sold 2,000 shares of common stock for approximately $170,000.